TESTO-TRIAL: Use of Testosterone in Critically Ill Patients
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-11-02
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate whether the use of the anabolic agent testosterone cypionate in critically ill patients, compared to placebo, increases the number of ventilator-free days